Cargando…
Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies
Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin lymphoma. The clinical course can be very heterogeneous with some patients being safely observed over many years without ever requiring treatment to other patients having more rapidly progressive disease requiring mul...
Autores principales: | Hanel, Walter, Epperla, Narendranath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247091/ https://www.ncbi.nlm.nih.gov/pubmed/34193230 http://dx.doi.org/10.1186/s13045-021-01113-2 |
Ejemplares similares
-
Emerging therapies in mantle cell lymphoma
por: Hanel, Walter, et al.
Publicado: (2020) -
Management of classical Hodgkin lymphoma: a look at up to date evidence and current treatment approaches
por: Hanel, Walter, et al.
Publicado: (2022) -
Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape
por: Subramanian, Janakiraman, et al.
Publicado: (2017) -
Survival of patients with transformed follicular lymphoma in the United States: a multiple cohort study
por: Vaughn, John L., et al.
Publicado: (2023) -
Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant
por: Liu, Qiuying, et al.
Publicado: (2021)